Table 1. Baseline characteristics of the patients at enrollment.
| Parameter | All Cases (n = 69) | Survivors(n = 24) | Non-Survivors(n = 45) | P-value |
|---|---|---|---|---|
| Age, years | 58 (48;65) | 51.5 (45.3;57.0) | 62 (53;67) | 0.005 |
| Male Gender, n (%) | 62 (89.9) | 21 (87.5) | 41 (91.1) | 0.687 |
| Body Mass Index, kg/m2 | 24.7 (22.5;27.3) | 24.1 (22.7;27.2) | 25.2 (21.8;27.3) | 0.940 |
| Sort of Device | ||||
| HeartMate II | 23 (33.3) | 5 (20.8) | 18 (40.0) | 0.179 |
| HeartWare | 46 (66.7) | 19 (79.2) | 27 (60.0) | 0.179 |
| Diagnosis | ||||
| Dilated Cardiomyopathy | 27 (39.1) | 11 (45.8) | 16 (35.6) | 0.446 |
| Ischemic Cardiomyopathy | 38 (55.1) | 11 (45.8) | 27 (60.0) | 0.314 |
| Others | 4 (5.8) | 2 (8.3) | 2 (4.4) | 0.606 |
| Hemodynamic Function | ||||
| LVEF, % | 20 (15;26) | 20 (16;25) | 20 (15;26) | 0.862 |
| LVEDD, mm | 70 (63;74) | 71 (63;81) | 68 (63;73) | 0.388 |
| Cardiac Index, L/min/m2 | 2.4 (1.8;2.7) | 2.1 (1.6;2.6) | 2.4 (1.8;2.8) | 0.467 |
| PAP, mmHg | 31 (22;39) | 34 (23;40) | 28 (22;38) | 0.208 |
| PVR, dyn·s/cm5 | 188 (128;280) | 253 (150;327) | 159 (118;269) | 0.053 |
| PCWP, mmHg | 19 (12;24) | 22 (16;24) | 18 (10;29) | 0.659 |
| INTERMACS Level | ||||
| 1 | 5 (7.2) | 0 (0) | 5 (11.1) | 0.155 |
| 2 | 15 (21.7) | 9 (37.5) | 6 (13.3) | 0.031 |
| 3 | 30 (43.5) | 10 (41.7)) | 20 (44.4) | >0.999 |
| 4 | 19 (27.5) | 5 (20.8) | 14 (31.1) | 0.411 |
| eGFR, ml/min/1.73m2 | 55.6 (39.4;81.5) | 74.9 (49.7;95.6) | 50.3 (34.6;70.1) | 0.018 |
| Hemoglobin (g/dl) | 11.0 (10.1;12.8) | 10.9 (9.6;12.0) | 11.2(10.1;12.8) | 0.508 |
| White Blood Cell Counts, 109/l | 8.6 (7.0;10.9) | 9.4 (7.8 (12.4) | 8.0 (6.7;10.8) | 0.147 |
Data are expressed as median and interquartile range or number (percentage). Abbreviations: eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; LVEDD, left ventricular enddiastolic diameter; PAP, pulmonary artery pressure; PVR, pulmonary vascular resistance; PCWP, pulmonary capillary wedge pressure